TT  UM Ventures

http://umventures.org





     Office Locations:

620 W. Lexington St. 4th flr
Baltimore, MD 21201
Phone: 410- 706-2380

 

Stages:

  • Early
  • Seed


 

Industries:

  • Education & Training
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Launched in 2012 by the University System of Maryland Board of Regents and the Governor of Maryland, University of Maryland Ventures (UM Ventures) is accelerating technology commercialization and advancing industry collaboration by integrating the entrepreneurial programs of the University of Maryland, Baltimore and College Park. UM Ventures is organized to move research outcomes into products and services, tools and diagnostics that will benefit society by mining the research fields at both the Baltimore and College Park campuses in search of collaborative projects with commercial value; and via mentoring and business advisory services with expert Entrepreneurs in Residence based at each campus and a team of technology licensing advisors targeting industry interest. The UM $75K Business Plan Competition promotes the commercialization of innovative ideas and University-created technologies by offering faculty, students, and alumni cash prizes for the best new venture plans.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Jim Hughes VP of Research and Development
    Julie Lenzer Director

     

    Portfolio companies include:


      A&G Pharmaceuticals
        web link


      BioAssay Works
        web link


      Fina Biosolutions
        web link


      Plasmonix
        web link


      Rexahn Pharmaceuticals
        web link


     

    Recent News: